Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
2.098
+0.088 (4.35%)
Jun 6, 2025, 2:56 PM - Market open
Entera Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 12.57 | 8.66 | 11.02 | 12.31 | 24.89 | 8.59 | Upgrade
|
| Cash & Short-Term Investments | 12.57 | 8.66 | 11.02 | 12.31 | 24.89 | 8.59 | Upgrade
|
| Cash Growth | 36.83% | -21.41% | -10.48% | -50.55% | 189.68% | -43.41% | Upgrade
|
| Receivables | 0.13 | 0.13 | - | 0.25 | 0.18 | 0.26 | Upgrade
|
| Prepaid Expenses | 0.35 | - | - | - | - | - | Upgrade
|
| Other Current Assets | 0.17 | 0.19 | 0.24 | 0.29 | 0.25 | 0.26 | Upgrade
|
| Total Current Assets | 21.22 | 8.97 | 11.26 | 12.85 | 25.33 | 9.11 | Upgrade
|
| Property, Plant & Equipment | 0.28 | 0.33 | 0.49 | 0.23 | 0.4 | 0.57 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | 0.01 | 0.04 | 0.22 | - | Upgrade
|
| Other Long-Term Assets | 0.1 | 0.09 | 0.01 | 0.01 | 0.05 | 0.05 | Upgrade
|
| Total Assets | 21.6 | 9.39 | 11.77 | 13.13 | 25.99 | 9.72 | Upgrade
|
| Accounts Payable | 0.13 | 0.13 | 0.08 | 0.02 | 0.17 | 0.16 | Upgrade
|
| Accrued Expenses | 1.03 | 0.87 | 0.87 | 1.23 | 2.67 | 1.33 | Upgrade
|
| Current Portion of Leases | 0.17 | 0.17 | 0.13 | 0.09 | 0.18 | 0.19 | Upgrade
|
| Current Income Taxes Payable | - | - | - | - | 0.13 | - | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 0.02 | 0.16 | Upgrade
|
| Other Current Liabilities | 0.3 | - | - | - | - | - | Upgrade
|
| Total Current Liabilities | 1.62 | 1.18 | 1.09 | 1.34 | 3.16 | 1.84 | Upgrade
|
| Long-Term Leases | 0.05 | 0.1 | 0.26 | - | 0.12 | 0.24 | Upgrade
|
| Other Long-Term Liabilities | 0.52 | - | - | - | - | - | Upgrade
|
| Total Liabilities | 2.22 | 1.31 | 1.38 | 1.37 | 3.42 | 2.21 | Upgrade
|
| Common Stock | 0 | 0 | 0 | - | - | - | Upgrade
|
| Additional Paid-In Capital | 135.83 | 121.97 | 114.73 | 107.21 | 104.95 | 77.71 | Upgrade
|
| Retained Earnings | -116.49 | -113.93 | -104.39 | -95.5 | -82.43 | -70.24 | Upgrade
|
| Comprehensive Income & Other | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | Upgrade
|
| Shareholders' Equity | 19.38 | 8.08 | 10.39 | 11.75 | 22.57 | 7.51 | Upgrade
|
| Total Liabilities & Equity | 21.6 | 9.39 | 11.77 | 13.13 | 25.99 | 9.72 | Upgrade
|
| Total Debt | 0.22 | 0.27 | 0.39 | 0.09 | 0.3 | 0.43 | Upgrade
|
| Net Cash (Debt) | 12.35 | 8.39 | 10.63 | 12.22 | 24.59 | 8.16 | Upgrade
|
| Net Cash Growth | 40.18% | -21.08% | -13.00% | -50.31% | 201.31% | -45.18% | Upgrade
|
| Net Cash Per Share | 0.31 | 0.22 | 0.37 | 0.42 | 0.94 | 0.44 | Upgrade
|
| Filing Date Shares Outstanding | 45.45 | 45.42 | 35.48 | 28.81 | 28.8 | 23.74 | Upgrade
|
| Total Common Shares Outstanding | 45.42 | 38.84 | 35.48 | 28.81 | 28.8 | 21.06 | Upgrade
|
| Working Capital | 19.6 | 7.8 | 10.17 | 11.51 | 22.17 | 7.27 | Upgrade
|
| Book Value Per Share | 0.43 | 0.21 | 0.29 | 0.41 | 0.78 | 0.36 | Upgrade
|
| Tangible Book Value | 19.38 | 8.08 | 10.39 | 11.75 | 22.57 | 7.51 | Upgrade
|
| Tangible Book Value Per Share | 0.43 | 0.21 | 0.29 | 0.41 | 0.78 | 0.36 | Upgrade
|
Updated Mar 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.